Corrigendum to "TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma" [EBioMedicine 40 (2019) 446-456]

EBioMedicine. 2022 Jun:80:104074. doi: 10.1016/j.ebiom.2022.104074. Epub 2022 May 20.
No abstract available

Publication types

  • Published Erratum